| MAYBANK KIM ENG | CGS CIMB |
Genting Singapore (GENS SP)
Sayonara Yokohama
D/G to HOLD with lower TP of SGD0.86 (-26%)
The Yokohama mayoral election resulted in the election of a resolutely anti-IR mayor. This almost certainly means that the Yokohama IR RFP process will be shelved. Though we still opine that the GENS-Sega Sammy JV was in the strongest position to win a Yokohama IR license, it is likely all academic now. Remove our previously ascribed SGD0.30/shr contribution from a Yokohama IR from our TP to arrive at a lower TP of SGD0.86. Downgrade to HOLD.
|
Wilmar International Regulator puts AWL’s IPO on hold
■ According to SEBI’s website, Adani Wilmar’s IPO is currently in abeyance. ■ AEL has not received any formal communication from SEBI on this issue. ■ This is negative as it could delay the listing of AWL, one of the two catalysts we projected for 2H21F.
|
|
PHILLIP SECURITIES |
|
|
Q & M Dental Group Ltd Rebound on track SINGAPORE | HEALTHCARE | 2Q21 RESULTS 23 August 2021
2Q21 PATMI within expectations, at 49% of our adjusted FY21e forecast. Revenue spiked 105% YoY to S$50.8mn. Normalised PATMI was up 10x. 1-for-5 bonus issue and 1 cent quarterly dividend announced. Earnings from Acumen Diagnostics’ COVID-19 PCR tests were an estimated S$3mn, up from S$0.6mn the previous quarter. Maintain BUY. Target price dips to S$0.98 from S$1.00 as we revamp our valuations. We now peg Acumen at S$60mn, at the proposed purchase price by Aoxin for a 49% stake. We roll over our 25x core P/E valuation to FY22e. Another S$0.04 has been added from the market value of listed associate, Aoxin Q & M Dental (S$0.225, Not Rated), at a 20% discount.
|
Check out our compilation of Target Prices
